Walter O. Whitley, OD EyeTube OD Filming and Lectures in Boston, MA

Dr. Walter Whitley, our Director of Optometric Services here at Virginia Eye Consultants, is currently in Boston, MA filming a variety of lectures for EyeTube OD

Some of the lectures included key speaking points on:

1.) A Special session with an expert panel reviewing the latest from the contact lens world-with emphasis on various age groups
2.) A course that will help explore the benefits of electronic health records/ case studies/ and the differences between vision and medical insurance
3.) Patient satisfaction and practice success, helping identify inter office processes.

We wish Dr. Whitley safe travels and are looking forward to seeing his videos posted at:

http://eyetubeod.com

*EyeTube OD is a Optometrist's video resource dedicated to all discussions on eye care.

Dr. Stephen V. Scoper, MD: ToberDexⓇST Guest Lecturer in Long Island, New York.

This past Thursday, February the 16^th, 2012, Dr. Stephen Scoper was a guest lecturer at a Physician’s meeting in Long Island, New York that discussed therapeutic strategies for blepharitis. Dr. Stephen Scoper discussed his experience in both diagnosing and treating interior and posterior blepharitis.

A majority of the lecture revolved around the scientific paper entitled: Ocular Distribution, Bactericidal Activity and Settling Characteristics of TobraDexⓇST Ophthalmic Suspension Compared with TobraDexⓇ Ophthalmic Suspension. Dr. Scoper was the lead author of this publishing that was responsible for gaining FDA approval for TobraDexⓇST.

Dr. Stephen Scoper walked the other Physicians through the details of the paper with the following conclusions:

• Suspension settling characteristics of ToberDexⓇST are outstanding, resulting in dose uniformity, because of the Xanthan gun vehicle with more bioavailbility.
• In-Vitro studies showed improved bactericidal activity leading to longer retention time and faster bacterial eradication.
• Human pharmacokinetic clinical studies showed equivalent concentrations of drug in the aqueous, despite ToberDexST having only half the dexamethasone.

In conclusion, these finding show that ToberDexⓇST is an excellent treatment for acute blepharitis.